Eye injection trial aims to slow vision loss in retinal diseases
NCT ID NCT07348588
Summary
This small, early-stage study is testing whether injections of an anti-inflammatory drug (adalimumab) into the eye can help preserve vision in people with inherited retinal diseases like retinitis pigmentosa (RP). Thirty participants will receive three injections over four months. The main goal is to see if the treatment is safe and if it can help slow the loss of visual field and central vision over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA (RP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rubens Siqueira Research Center
São José do Rio Preto, São Paulo, 15010-100, Brazil
Conditions
Explore the condition pages connected to this study.